News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Teck reported Q2 adjusted EBITDA of CAD 2.2 billion.
  • Teck posted adjusted profit attributable of CAD 948 million.
  • Higher copper production and record copper prices drove Teck's results.
  • Teck advanced its planned merger with Anglo American.
  • Renesas acquired Wolfspeed assets, positioning for automotive and power semiconductor growth.
  • Analyst upgraded Renesas to Buy, targeting a mid-term rebound to $15.50.

Latest Articles

Riyadh Air Negotiates Major Widebody Jet Purchases from Airbus and Boeing

Riyadh Air Negotiates Major Widebody Jet Purchases from Airbus and Boeing

Riyadh Air is negotiating purchases of additional widebody aircraft with Airbus (EPA:AIR) and Boeing (NYSE:BA), including around six A350-1000s and roughly 30 Boeing jets, as the state-owned Saudi carrier scales its fleet and international network. The agreement is expected to be announced at the Farnborough International Airshow next week, accordi…

BridgeBio Pharma Director Andrea Ellis Sells $1.44M in Stock

BridgeBio Pharma Director Andrea Ellis Sells $1.44M in Stock

BridgeBio Pharma, Inc. (NASDAQ: BBIO) director Andrea Ellis executed a sale of $1,442,028 in company stock on July 9, 2026. The transaction, covering 17,167 shares at $84.00 per share, was conducted under a pre-established Rule 10b5-1 plan adopted in December 2025. This sale coincides with a period of significant corporate activity for BridgeBio, i…

BridgeBio Pharma Director Jennifer Cook Executes Complex Share Transactions Amid Clinical and Capital Updates

BridgeBio Pharma Director Jennifer Cook Executes Complex Share Transactions Amid Clinical and Capital Updates

Jennifer E. Cook, a director at BridgeBio Pharma, Inc. (NASDAQ: BBIO), executed a series of complex transactions on July 9, 2026, involving the sale and acquisition of company stock. The director sold 148,589 shares valued at approximately $13.16 million under a Rule 10b5-1 plan, while simultaneously acquiring an equal number of shares through stoc…

BillionToOne Chief Executive Oguzhan Atay Offloads $1.57 Million in Equity

BillionToOne Chief Executive Oguzhan Atay Offloads $1.57 Million in Equity

Oguzhan Atay, Chairman and Chief Executive Officer of BillionToOne, Inc. (NASDAQ:BLLN), executed a sale of 12,500 shares of Class A Common Stock on July 9, 2026, realizing approximately $1.57 million in proceeds. The transactions were facilitated through a pre-existing Rule 10b5-1 trading plan established in March 2026. Despite the executive divest…

BillionToOne CPO Shan Riku Sakakibara Executes Pre-Arranged Stock Sale

BillionToOne CPO Shan Riku Sakakibara Executes Pre-Arranged Stock Sale

BillionToOne, Inc. (NASDAQ:BLLN) Chief Product Officer Sakakibara Shan Riku completed a $1,000,000 sale of 8,000 Class A Common Stock shares on July 9, 2026. The transaction, executed at $125 per share, was facilitated through a Rule 10b5-1 trading plan established on March 6, 2026. Concurrently, Sakakibara exercised fully vested stock options to a…

Datadog Director Amit Agarwal Disposes of $5.35 Million in Class A Shares

Datadog Director Amit Agarwal Disposes of $5.35 Million in Class A Shares

Datadog, Inc. (NASDAQ:DDOG) director Amit Agarwal has executed a significant sale of Class A Common Stock shares. The transaction, valued at approximately $5.35 million, was carried out through a pre-arranged trading plan. This activity occurs as the company faces contrasting analyst outlooks and continues its strategic focus on artificial intellig…

MBX Biosciences Names New CEO and CFO as Shares Drop After-Hours

MBX Biosciences Names New CEO and CFO as Shares Drop After-Hours

MBX Biosciences announced that Executive Chairman Steve Hoerter will assume the roles of Chairman and Chief Executive Officer immediately, replacing Kent Hawryluk, who resigned as President, CEO and board member. The company also named John Smither, interim CFO since March 2026, as its permanent Chief Financial Officer. Shares fell 8.3% in after-ho…

Fluence Signs Rexford 2 Storage Contract, Shares Tick Up After-Hours

Fluence Signs Rexford 2 Storage Contract, Shares Tick Up After-Hours

Fluence Energy (NASDAQ:FLNC) saw its stock rise 4% in after-hours trading after announcing a contract with Avantus to deliver energy storage systems and turnkey Engineering, Procurement and Construction services for the Rexford 2 project in Southern California. The project will pair a 200 MW / 800 MWh Smartstack battery with a solar facility in Tul…

Fluence to Provide U.S. Domestic Content Smartstack System for Avantus 800 MWh Rexford 2 Project in Southern California

Fluence to Provide U.S. Domestic Content Smartstack System for Avantus 800 MWh Rexford 2 Project in Southern California

Fluence Energy, Inc. announced a contract with Avantus to deliver its Smartstack energy storage system with U.S. domestic content and turnkey EPC services for the 200 MW / 800 MWh Rexford 2 project in Tulare County, California. The project will combine battery storage with solar power to provide clean, reliable energy for Southern California, suppo…

Sanuwave Health Reports Preliminary Q2 2026 Revenue of $9.6–$9.8 Million, Above High End of Revised Guidance

Sanuwave Health Reports Preliminary Q2 2026 Revenue of $9.6–$9.8 Million, Above High End of Revised Guidance

Sanuwave Health, Inc. reported preliminary Q2 2026 revenues between $9.6 and $9.8 million, exceeding the top end of its revised guidance. Although this represents a 3-5% decline from Q2 2025 revenues of $10.1 million, strong sales in consumable applicators, which reached record highs, point to increasing market confidence and future growth opportun…

Erasca Announces $500M Common Stock Offering; Shares Drop After Hours

Erasca Announces $500M Common Stock Offering; Shares Drop After Hours

Erasca disclosed a proposed underwritten public offering of $500 million in common equity, prompting a 12% decline in the company’s shares in after-hours trading. The financing includes a 30-day option for underwriters to buy up to an extra $75 million of shares. Proceeds are intended to support development programs, research and development of pro…

Stifel Picks NVIDIA and AMD as Top Processor Plays Ahead of Earnings

Stifel Picks NVIDIA and AMD as Top Processor Plays Ahead of Earnings

Stifel has singled out two chipmakers as its preferred processor stocks entering the June-July earnings cycle, identifying NVIDIA as its top large-cap pick and AMD as a complementary exposure to accelerated computing. The firm highlights AI-driven demand, constrained compute capacity, and company-specific product ramps as the core catalysts behind …

Grace & Mercy Foundation Expands Gloo Holdings Stake in $3M Offering

Grace & Mercy Foundation Expands Gloo Holdings Stake in $3M Offering

Grace & Mercy Foundation, Inc. has increased its direct ownership in Gloo Holdings, Inc. (NASDAQ:GLOO) through a recent purchase of Class A Common Stock. The transaction, executed as part of a broader firm commitment underwritten public offering, underscores the foundation's continued capital allocation into the company. This activity occurs agains…

Insteel’s Shakeout Offers a Clear Rebound Trade: Upgrade to Buy

Insteel’s Shakeout Offers a Clear Rebound Trade: Upgrade to Buy

Insteel Industries plunged earlier this year on margin compression and weather-driven shipping weakness. That sell-off appears overdone: IIIN trades at ~13.4x earnings and EV/EBITDA of 7.5 with no debt, a $559M market cap, and a 52-week range that leaves room for mean reversion. We upgrade to a tactical buy with a defined entry, stop and target for…